Can non-contrast magnetic resonance imaging replace contrast-enhanced computerized tomography in the local staging of pediatric renal tumors?

被引:1
|
作者
Romeih, Marwa [1 ]
Mahrous, Mary Rabea [2 ]
Raafat, Tarek Ahmed [3 ]
Mahmoud, Esmat [3 ]
机构
[1] Helwan Univ, Fac Med, Radiodiag Dept, Cairo, Egypt
[2] Natl Heart Inst, Radiodiag Dept, Cairo, Egypt
[3] Cairo Univ, NCI, Radiodiag Dept, Cairo, Egypt
来源
EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE | 2024年 / 55卷 / 01期
关键词
MRICT; Staging pediatric renal tumors; NEOPLASMS;
D O I
10.1186/s43055-024-01194-2
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundRenal tumors account for approximately 6-7% of the total incidence of pediatric cancers. Wilms tumor (WT) is the most common renal malignancy observed in the pediatric population under 5 years old. Computed tomography (CT) is used for staging of the renal tumors. Magnetic resonance imaging (MRI) offers enhanced soft tissue resolution and provides more comprehensive insights into tumor extension through the capsule, including tumor infiltration into the renal vein or IVC. MRI is a noninvasive imaging modality that does not involve any radiation hazards, making it safe for children. In addition, MRI can be performed without the administration of contrast agents in patients with impaired renal function. Therefore, MRI plays a vital role in screening, staging, preoperative evaluation, and follow-up. Diffusion-weighted imaging (DWI) is a functional tool that aids in locating the most receptive tumoral region to guide confirmatory biopsies. In this study, we aim to evaluate the potential value of non-contrast MRI in staging pediatric renal tumors compared to contrast-enhanced CT.ResultsThis study included 50 patients presented with renal mass, with ages ranging from 1 to 8 years and a mean age of 4.27 +/- 1.27 (mean +/- SD). The final diagnosis was Wilm's tumor at 86%, clear cell sarcoma at 4%, rhabdoid tumor at 4%, rhabdomyosarcoma at 2%, and nephroblastomatosis with no malignant transformation at 4%. CT accurately diagnosed stages 4 and 5 in agreement with pathological findings while upstaging the other cases, with a CT sensitivity of 90.91%, specificity of 82.35%, PPV of 92%, and NPV of 84%. MRI is superior to CT in stages 1 and 3, accurately diagnosing stages 2, 4, and 5, with a sensitivity of 93.30%, specificity of 95.65%, PPV of 95%, and NPV of 97%.ConclusionsNon-contrast MRI could be considered the optimal radiation-free imaging modality in staging pediatric renal tumors mainly Wilm's tumor as it offers high sensitivity and specificity of capsular and vascular infiltration, compared to contrast-enhanced CT especially in cases with impaired renal functions.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Tumors: Preclinical Validation of Parametric Images
    Egeland, Tormod A. M.
    Simonsen, Trude G.
    Gaustad, Jon-Vidar
    Gulliksrud, Kristine
    Ellingsen, Christine
    Rofstad, Einar K.
    RADIATION RESEARCH, 2009, 172 (03) : 339 - 347
  • [42] Magnetic Resonance Imaging of Parotid Gland Tumors: Dynamic Contrast-Enhanced Sequence Evaluation
    Stefanovic, Xavier
    Al Tabaa, Yassine
    Gascou, Gregory
    Lacombe, Sandy
    Auge, Yves
    Delort, Philippe
    Hagen, Paul
    Garrel, Renaud
    Bonafe, Alain
    Daures, Jean-Pierre
    Vendrell, Jean-Francois
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2017, 41 (04) : 541 - 546
  • [43] Dynamic contrast-enhanced magnetic resonance imaging in radiotherapeutic efficacy in the head and neck tumors
    Tomura, N
    Omachi, K
    Sakuma, I
    Takahashi, S
    Izumi, J
    Watanabe, O
    Watarai, J
    Sageshima, M
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2005, 26 (03) : 163 - 167
  • [44] Contrast-Enhanced Spectral Detector Computed Tomography in the detection of Myocardial Fibrosis: Comparison to Contrast-Enhanced Magnetic Resonance
    Defaee, Asefeh
    Gerber, Berhard
    ACTA CARDIOLOGICA, 2020, 75 : 28 - 29
  • [45] Locoregional staging of breast cancer: contrast-enhanced mammography versus breast magnetic resonance imaging
    Terzoni, Andrea
    Basile, Paola
    Gambaro, Anna Clelia
    Attanasio, Silvia
    Rampi, Anna Maria
    Brambilla, Marco
    Carriero, Alessandro
    RADIOLOGIA MEDICA, 2024, 129 (04): : 558 - 565
  • [46] Locoregional staging of breast cancer: contrast-enhanced mammography versus breast magnetic resonance imaging
    Andrea Terzoni
    Paola Basile
    Anna Clelia Gambaro
    Silvia Attanasio
    Anna Maria Rampi
    Marco Brambilla
    Alessandro Carriero
    La radiologia medica, 2024, 129 : 558 - 565
  • [47] Contrast-Enhanced Magnetic Resonance Imaging in Pediatric Patients: Review and Recommendations for Current Practice
    Bhargava, Ravi
    Hahn, Gabriele
    Hirsch, Wolfgang
    Kim, Myung-Joon
    Mentzel, Hans-Joachim
    Olsen, Oystein E.
    Stokland, Eira
    Triulzi, Fabio
    Vazquez, Elida
    MAGNETIC RESONANCE INSIGHTS, 2013, 6 : 95 - 111
  • [48] Non-contrast computed tomography and magnetic resonance imaging features of mucoepidermoid carcinoma in the salivary glands
    Shoko Gamoh
    Hironori Akiyama
    Kaname Tsuji
    Tetsuro Nakazawa
    Shosuke Morita
    Akio Tanaka
    Kimishige Shimizutani
    Oral Radiology, 2018, 34 : 24 - 30
  • [49] Non-contrast computed tomography and magnetic resonance imaging features of mucoepidermoid carcinoma in the salivary glands
    Gamoh, Shoko
    Akiyama, Hironori
    Tsuji, Kaname
    Nakazawa, Tetsuro
    Morita, Shosuke
    Tanaka, Akio
    Shimizutani, Kimishige
    ORAL RADIOLOGY, 2018, 34 (01) : 24 - 30
  • [50] Measuring tumor perfusion in control and treated murine tumors - Correlation of microbubble contrast-enhanced Sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography
    Niermann, Kenneth J.
    Fleischer, Arthur C.
    Huamani, Jessica
    Yankeelov, Thomas E.
    Kim, Dong W.
    Wilson, Wendy D.
    Hallahan, Dennis E.
    JOURNAL OF ULTRASOUND IN MEDICINE, 2007, 26 (06) : 749 - 756